(Taken directly from the application) Corticotropin-releasing factor (CRF) and CRF-related neuropeptides have an important role in the central nervous system mediating behavioral responses to stressors. CRF receptor antagonists are very effective in reversing stress-induced suppression and activation in behavior. Brain sites implicated in the behavioral effects of CRF include the locus coeruleus, paraventricular nucleus of the hypothalamus, the bed nucleus of the stria-terminalis, and the central nucleus of the amygdala. The present series of proposed studies is to further explore the role of CRF related neuropeptides in activation, behavioral responses to stressors and feeding. An additional CRF-like neuropeptide, urocortin, has been identified in the brain and has a high affinity for the CRF-2 receptor in addition to the CRF-l receptor. Urocortin has many of the effects of CRF but also is significantly more potent and effective than CRF in decreasing feeding in both meal-deprived and free-feeding rats.
In Specific Aim 1, the brain sites that are most sensitive to the effects of CRF will be compared to the brain sites most sensitive to the effects of urocortin using intracranial microinjection of CRF related neuropeptides. The neuropharmacological mechanisms involved in mediating the activation, stress-enhancing and suppression of feeding produced by CRF and urocortin will be explored in Specific Aim 2. In mouse genetic models, mice over-expressing CRF show anxiogenic-like responses compared to wild-type mice, and mice lacking the CRF-I receptor showed a behavioral profile of decreased behavioral responses to stressors, compared to wild-type nice. Results to date have led to the hypothesis that CRF-I receptors may mediate CRF-like neuropeptide-effects on activation and behavioral responses to stressors, but CRF-2 receptors may mediate the suppression of feeding produced by CRF-like neuropeptides. This hypothesis will be further explored in Specific Aim 3 where systematic assessment of the effects of CRF and urocortin on activation, behavioral responses to stressors and feeding will be explored in CRF-1, CRF-2 and CRF-I /CRF-2 knockout mice. Finally in Specific Aim 4, novel-ligands and/or CRF receptors developed under the auspices of the Program Project will be assessed using sensitive behavioral tests of activation, behavioral responses to stressors and feeding in rats and mice. Results of the present series of studies will provide key information regarding the role of CRF related neuropeptides in central nervous system function and may provide insights into the possible role of CRF in a variety of stress related psychopathology.

Project Start
2001-06-01
Project End
2002-05-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
22
Fiscal Year
2002
Total Cost
$148,636
Indirect Cost
Name
Salk Institute for Biological Studies
Department
Type
DUNS #
005436803
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Spierling, Samantha R; Mattock, Maegan; Zorrilla, Eric P (2017) Modeling hypohedonia following repeated social defeat: Individual vulnerability and dopaminergic involvement. Physiol Behav 177:99-106
Erchegyi, Judit; Wang, Lixin; Gulyas, Jozsef et al. (2016) Characterization of Multisubstituted Corticotropin Releasing Factor (CRF) Peptide Antagonists (Astressins). J Med Chem 59:854-66
Pilbrow, Anna P; Lewis, Kathy A; Perrin, Marilyn H et al. (2016) Cardiac CRFR1 Expression Is Elevated in Human Heart Failure and Modulated by Genetic Variation and Alternative Splicing. Endocrinology 157:4865-4874
Zhang, Cheng; Kuo, Ching-Chang; Moghadam, Setareh H et al. (2016) Corticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease. Alzheimers Dement 12:527-37
Cui, Changhai; Noronha, Antonio; Warren, Kenneth R et al. (2015) Brain pathways to recovery from alcohol dependence. Alcohol 49:435-52
Perrin, Marilyn H; Tan, Laura A; Vaughan, Joan M et al. (2015) Characterization of a Pachymedusa dacnicolor-Sauvagine analog as a new high-affinity radioligand for corticotropin-releasing factor receptor studies. J Pharmacol Exp Ther 353:307-17
Zhang, Cheng; Kuo, Ching-Chang; Moghadam, Setareh H et al. (2015) Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model. J Alzheimers Dis 45:639-50
van der Meulen, Talitha; Huising, Mark O (2015) Role of transcription factors in the transdifferentiation of pancreatic islet cells. J Mol Endocrinol 54:R103-17
Radley, Jason J; Sawchenko, Paul E (2015) Evidence for involvement of a limbic paraventricular hypothalamic inhibitory network in hypothalamic-pituitary-adrenal axis adaptations to repeated stress. J Comp Neurol 523:2769-87
van der Meulen, Talitha; Donaldson, Cynthia J; Cáceres, Elena et al. (2015) Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion. Nat Med 21:769-76

Showing the most recent 10 out of 382 publications